Stifel Financial’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Buy |
20,651
+6,936
| +51% | +$37.9K | ﹤0.01% | 3351 |
|
|
2025
Q1 | $86.3K | Buy |
13,715
+2,700
| +25% | +$17K | ﹤0.01% | 3303 |
|
|
2024
Q4 | $45.4K | Sell |
11,015
-298
| -3% | -$1.23K | ﹤0.01% | 3321 |
|
|
2024
Q3 | $37.8K | Sell |
11,313
-990
| -8% | -$3.31K | ﹤0.01% | 3314 |
|
|
2024
Q2 | $36.7K | Buy |
12,303
+2,200
| +22% | +$6.56K | ﹤0.01% | 3296 |
|
|
2024
Q1 | $34.9K | Buy |
10,103
+3
| +0% | +$10 | ﹤0.01% | 3280 |
|
|
2023
Q4 | $13.5K | Buy |
+10,100
| New | +$13.5K | ﹤0.01% | 3283 |
|
|
2020
Q2 | – | Sell |
-13,845
| Closed | -$46K | – | 2948 |
|
|
2020
Q1 | $46K | Sell |
13,845
-10,707
| -44% | -$35.6K | ﹤0.01% | 2666 |
|
|
2019
Q4 | $91K | Sell |
24,552
-13
| -0.1% | -$48 | ﹤0.01% | 2895 |
|
|
2019
Q3 | $111K | Buy |
+24,565
| New | +$111K | ﹤0.01% | 2754 |
|